Quantbot Technologies’s Eidos Therapeutics EIDX Stock Holding History
Bought
Maintained
Sold
Quantbot Technologies's EIDX Position: Q1 2021 in Review
Quantbot Technologies sold out of Eidos Therapeutics (EIDX) in Q1 2021, closing a stake of 200 shares — an estimated $26K sold.
Quantbot Technologies first reported a position in EIDX in Q3 2019 and held it in 3 quarters. The position peaked at $213K in Q4 2019. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.
- Quantbot Technologies reported no remaining Eidos Therapeutics position as of Q1 2021 after selling out during the quarter.
- Quantbot Technologies sold 200 Eidos Therapeutics shares in Q1 2021, an estimated $26K.
- Quantbot Technologies first reported a position in Eidos Therapeutics in Q3 2019 and held it in 3 quarters.
- Quantbot Technologies's Eidos Therapeutics position peaked at $213K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Eidos Therapeutics as of Q1 2021.
Based on Quantbot Technologies's 13F filing for Q1 2021, filed 14 May 2021.